Top Markets
Coin of the day
Aelis Farma S.A. Aelis Farma S.A.

Aelis Farma S.A.

AELIS
Peringkat dalam Saham #30387
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
Harga Saham
$1.25
Terakhir disinkronkan: 2026-08-18
Kapitalisasi Pasar
$17.05M
Perubahan (1 hari)
-1.50%
Perubahan (1 tahun)
-22.24%
Negara
FR
Perdagangan Aelis Farma S.A. (AELIS)

Kategori

Riwayat hasil dividen untuk Aelis Farma S.A. (AELIS)
Hasil dividen (TTM) dari Aelis Farma S.A. (simbol saham: AELIS) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Aelis Farma S.A. (AELIS) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE